Caveolin 2

01/01/2021 - "This study uses caveolin-2-deficient mouse and small intestinal I/R injury models to examine the role of caveolin-2 in the leukocyte-dependent reperfusion injury. "
04/17/2018 - "This study demonstrates that inhibition of TRPV4 ameliorates BBB leakage induced by ischemia-reperfusion injury through the downregulation of caveolin-1 and caveolin-2."
01/01/2021 - "We demonstrate for the first time that caveolin-2 plays a protective role from the I/R-induced leukocyte-dependent reperfusion injury by reducing PAI-1 protein levels in intestinal tissue and leukocyte-endothelial adhesive interactions in postcapillary venules."

02/01/2014 - "The CAV1/CAV2 (caveolin 1 and caveolin 2) genomic region previously was associated with primary open-angle glaucoma (POAG), although replication among independent studies has been variable. "
08/01/2013 - "The caveolin 1 to caveolin 2 (CAV1-CAV2) gene region on chromosome 7q31 has been reported to be associated with susceptibility to primary open angle glaucoma (POAG) and normal tension glaucoma (NTG) in previous studies. "

12/12/2019 - "Caveolin-2 deficiency induces a rapid anti-tumor immune response prior to regression of implanted murine lung carcinoma tumors."
11/15/2014 - "Host deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis."
05/01/2001 - "Expression of caveolin-2 was undetectable in all of the normal colonic glands, adenomas, and carcinomas. "
01/01/2021 - "We have previously reported that caveolin-2 (Cav-2), a protein component of plasma membrane caveolae, regulated leukocyte infiltration in mouse lung carcinoma tumors. "
07/01/2003 - "Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation."

07/01/2008 - "Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis."
08/15/2011 - "Our findings suggest that MiR-199a-3p targeting of caveolin-2 might have an important role in breast cancer tumor progression, making it a potential candidate for intervention in cancer."
01/27/2015 - "Finally, both syndecan-2 and caveolin-2 were upregulated in tissue arrays from breast cancer patients compared to normal mammary tissue. "
01/27/2015 - "Immunohistochemistry for syndecan-2 and its interacting partner, caveolin-2 was performed on human breast tumor tissue arrays. "
07/22/2008 - "Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype."

07/01/2023 - "These findings indicate that cadherin switch and caveolin-2 immunoexpression may be regulatory events in oral carcinogenesis."
07/01/2023 - "Differential expression of Cadherins switch and Caveolin-2 during stages of oral carcinogenesis."
07/01/2023 - "This study aimed to analyse the immunoexpression of E-cadherin, N-cadherin and caveolin-2 at different stages of oral carcinogenesis to identify reliable biomarkers to predict malignant potential. "
05/01/2001 - "We studied the expression of caveolin-1 and caveolin-2 in normal epithelium, adenoma, and adenocarcinoma of the colon and their possible role in tumorigenesis. "